TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30CA016058
National Institutes of Health
Grant: R35CA198183
National Institutes of Health
Grant: F30CA265281
National Institutes of Health
Grant: F31CA254151
National Institutes of Health
Grant: 3P30CA016058-15S1
CORE--HORMONE RECEPTOR LABORATORY
National Institutes of Health
Grant: 5F30CA265281-04
The role of PTPN11 and NPM1 mutations in acute myeloid leukemia development and therapy resistance
National Institutes of Health
Grant: 1F31CA254151-01
Intentional Modulation of Ibrutinib Pharmacokinetics through CYP3A Inhibition
OSU Comprehensive Cancer Center Pelotonia foundation
Pelotonia Fellowship Program
FWCI
1.48
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals